Ignite Creation Date:
2024-05-06 @ 3:05 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04513379
Status:
UNKNOWN
Last Update Posted:
2020-08-14
First Post:
2020-08-12
Brief Title:
Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIVTB Co-infected Patients
Sponsor:
Shanghai Public Health Clinical Center
Organization:
Shanghai Public Health Clinical Center
Organization Data
Organization:
Shanghai Public Health Clinical Center
Class:
OTHER_GOV
Study ID:
EDOSE
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Public Health Clinical Center
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Jun Chen
Responsible Party Title:
Shanghai Public Health Clinical Center
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shanghai Public Health Clinical Center
Old Name:
None
Old Organization:
None